The fluid mechanics of cancer and its therapy

Annual Review of Fluid Mechanics

Volumn 45, Issue , 2013, Pages 325-355

  Koumoutsakos, Petros ^a   Pivkin, Igor ^b   Milde, Florian ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF LUGANO   (Switzerland)

Author keywords

angiogenesis; blood flow; nanoparticles; tumor

Indexed keywords

ANGIOGENESIS; BLOOD FLOW; CANCER CELLS; CANCEROUS TISSUES; FLOW-STRUCTURE INTERACTION; MULTISCALES; PREDICTIVE MODELING; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULATURE;

BLOOD VESSELS; DISEASES; DRUG DELIVERY; FLUID MECHANICS; NANOPARTICLES; PATHOLOGY; TUMORS;

DIAGNOSIS;

BLOOD; CANCER; CYTOLOGY; DRUG; EXPERIMENTAL STUDY; FLOW STRUCTURE; FLUID MECHANICS; NANOTECHNOLOGY; OXYGEN; TUMOR;

EID: 84872227019     PISSN: 00664189     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-fluid-120710-101102     Document Type: Article

References (212)

1. Adams R, Alitalo K. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 8:464-78.
2. Adamson RH, Lenz JE, Zhang X, Adamson GN, Weinbaum S, Curry FE. 2004. Oncotic pressures opposing. filtration across non-fenestrated rat microvessels. J. Physiol. 557:889-907.
3. Algire G, Chalkley H. 1945. Vascular reactions of normal and malignant tissues in vivo. 1. Vascular reactions. of mice to wounds and to normal and neoplastic transplants. J. Natl. Cancer Inst. 6:73-85.
4. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. 2000. Intravascular origin of metastasis. from the proliferation of endothelium-attached tumor cells: a newmodel for metastasis. Nat. Med. 6:100-2.
5. Alunni-Fabbroni M, Sandri MT. 2010. Circulating tumour cells in clinical practice: methods of detection and. possible characterization. Methods 50:289-97.
6. Baish JW, Stylianopoulos T, Lanning RM, Kamoun WS, Fukumura D, et al. 2011. Scaling rules for diffusive. drug delivery in tumor and normal tissues. Proc. Natl. Acad. Sci. USA 108:1799-803.
7. Balding D, McElwain DLS. 1985. A mathematical model of tumour-induced capillary growth. J. Theor. Biol. 114:53-73.
8. Balligand JL, Feron O, Dessy C. 2009. eNOS activation by physical forces: from short-term regulation of. contraction to chronic remodeling of cardiovascular tissues. Physiol. Rev. 89:481-534.
9. Bauer AL, Jackson TL, Jiang Y. 2009. Topography of extracellular matrix mediates vascular morphogenesis. and migration speeds in angiogenesis. PLoS Comput. Biol. 5:e1000445.
10. Bell GI. 1978. Models for specific adhesion of cells to cells. Science 200:618-27.
11. Bergdorf M, Milde F, Koumoutsakos P. 2010. Continuum models of mesenchymal cellmigration and sprouting. angiogenesis. In Multiscale Cancer Modeling, ed. TDeisboeck, GS Stamatakos, pp. 213-35. Boca Raton,. FL: CRC.
12. Bergers G, Hanahan D. 2008. Modes of resistance to antiangiogenic therapy. Nat. Rev. Cancer 8:592-603.
13. Boal DH, Seifert U, Zilker A. 1992. Dual network model for red-blood-cell membranes. Phys. Rev. Lett. 69:3405-8.
14. Borsig L. 2011. Glycans in cancer. In Glycans in Diseases and Therapeutics, ed. MS Paṽao, pp. 63-81. Berlin:. Springer.
15. Brigger I, Dubernet C, Couvreur P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54:631-51.
16. Burri PH, Hlushchuk R, Djonov V. 2004. Intussusceptive angiogenesis: its emergence, its characteristics, and. its significance. Dev. Dyn. 231:474-88.
17. Carmeliet P. 2003. Angiogenesis in health and disease. Nat. Med. 9:653-60.
18. Carmeliet P. 2005. Angiogenesis in life, disease and medicine. Nature 438:932-36.
19. Chambers A, Groom A, MacDonald I. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2:563-72.
20. Chaplain MA. 2000. Mathematical modelling of angiogenesis. J. Neurooncol. 50:37-51.
21. Chapman GB, Cokelet GR. 1998. Flow resistance and drag forces due to multiple adherent leukocytes in. postcapillary vessels. Biophys. J. 74:3292-301.
22. Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. 2011. Delivery of molecular and nanoscale medicine to. tumors: transport barriers and strategies. Annu. Rev. Chem. Biomol. Eng. 2:281-98.
23. Chung AS, Lee J, Ferrara N. 2010. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer 10:505-14.
24. Cullen JP, Sayeed S, Sawai RS, Theodorakis NG, Cahill PA, et al. 2002. Pulsatile flow-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22:1610-16.
25. Damiano ER, Duling BR, Ley K, Skalak TC. 1996. Axisymmetric pressure-driven flow of rigid pellets through a cylindrical tube lined with a deformable porous wall layer. J. Fluid Mech. 314:163-89.
26. Davies JA. 2005. Mechanisms of Morphogenesis. Philadelphia: Elsevier.
27. Davis ME, Chen ZG, Shin DM. 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7:771-82.
28. Demou Z. 2010. Gene expression profiles in 3D tumor analogs indicate compressive strain differentially. enhances metastatic potential. Ann. Biomed. Eng. 38:3509-20.
29. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, et al. 2004. Tenascin-C and SF/HGF. produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells. through RhoA and Rac. FASEB J. 18:1016-18.
30. DiResta GR, Nathan SS, Manoso MW, Casas-Ganem J, Wyatt C, et al. 2005. Cell proliferation of cultured. human cancer cells are affected by the elevated tumor pressures that exist in vivo. Ann. Biomed. Eng. 33:1270-80.
31. Discher DE, Boal DH, Boey SK. 1998. Simulations of the erythrocyte cytoskeleton at large deformation. II. Micropipette aspiration. Biophys. J. 75:1584-97.
32. Djonov V, Baum O, Burri P. 2003. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res. 314:107-17.
33. Djonov V, Kurz H, Burri P. 2002. Optimality in the developing vascular system: branching remodeling by. means of intussusception as an efficient adaptation mechanism. Dev. Dyn. 224:391-402.
34. Dupin MM, Halliday I, Care CM, Munn LL. 2008. Lattice Boltzmann modelling of blood cell dynamics. Int. J. Comput. Fluid Dyn. 22:481-92.
35. Dvorak HF. 1986. Tumors: wounds that do not heal. N. Engl. J. Med. 315:1650-59.
36. Dvorak HF. 1987. Thrombosis and cancer. Hum. Pathol. 18:275-84.
37. Dvorak HF, Nagy J, Dvorak J, Dvorak A. 1988. Identification and characterization of the blood vessels of. solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133:95-109.
38. Ebos JML, Kerbel RS. 2011. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat. Rev. Clin. Oncol. 8:210-21.
39. Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: complex tissues that interface with the entire. organism. Dev. Cell 18:884-901.
40. Egginton S. 2011. Physiological factors influencing capillary growth. Acta Physiol. 202:225-39.
41. Eggleton CD, Popel AS. 1998. Large deformation of red blood cell ghosts in a simple shear flow. Phys. Fluids. 10:1834-45.
42. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126:677-89.
43. Fedosov DA, Caswell B, Popel AS, Karniadakis GE. 2010. Blood flow and cell-free layer in microvessels. Microcirculation 17:615-28.
44. Fedosov DA, Fornleitner J, Gompper G. 2012. Margination of white blood cells in microcapillary flow. Phys. Rev. Lett. 108:028104.
45. Ferrara N, Kerbel RS. 2005. Angiogenesis as a therapeutic target. Nature 438:967-74.
46. Ferrari M. 2010. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol. 28:181-88.
47. Fidler IJ. 2003. The pathogenesis of cancermetastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer. 3:453-58.
48. Folkman J. 2006. Angiogenesis. Annu. Rev. Med. 57:1-18.
49. Folkman J, Bach M, Rowe J, Davidoff F, Lambert P, et al. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-86.
50. Folkman J, Hahnfeldt P, Hlatky L. 2000. Cancer: looking outside the genome. Nat. Rev. Mol. Cell Biol. 1:76-79.
51. Freund JB, Orescanin MM. 2011. Cellular flow in a small blood vessel. J. Fluid Mech. 671:466-90.
52. Frey-Wyssling A. 1952. Deformation and Flow in Biological Systems. Amsterdam: North-Holland.
53. Friedl P, Wolf K. 2003. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3:362-74.
54. Galluzzi L, Kroemer G. 2008. Necroptosis: a specialized pathway of programmed necrosis. Cell 135:1161-63.
55. Geng Y, Marshall J, King M. 2012. Glycomechanics of the metastatic cascade: tumor cell-endothelial cell. interactions in the circulation. Ann. Biomed. Eng. 40:790-805.
56. Gjorevski N, Nelson CM. 2010. Endogenous patterns of mechanical stress are required for branching morphogenesis. Integr. Biol. 2:424-34.
57. Goel S, Duda D, Xu L, Munn L, Boucher Y, et al. 2011. Normalization of the vasculature for treatment of. cancer and other diseases. Physiol. Rev. 91:1071-121.
58. Gomez EW, Chen QK, Gjorevski N, Nelson CM. 2010. Tissue geometry patterns epithelial-mesenchymal. transition via intercellular mechanotransduction. J. Cell. Biochem. 110:44-51.
59. Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell 140:883-99.
60. Gupta GP, Massague J. 2006. Cancer metastasis: building a framework. Cell 127:679-95.
61. Hadjipanayi E, Mudera V, Brown RA. 2009. Guiding cell migration in 3D: a collagen matrix with graded. directional stiffness. Cell Motil. Cytoskelet. 66:121-28.
62. Hammer DA, Apte SM. 1992. Simulation of cell rolling and adhesion on surfaces in shear flow: general results. and analysis of selectin-mediated neutrophil adhesion. Biophys. J. 63:35-57.
63. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-64.
64. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
65. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-74.
66. Hansen JC, Skalak R, Chien S, Hoger A. 1997. Influence of network topology on the elasticity of the red. blood cell membrane skeleton. Biophys. J. 72:2369-81.
67. Helmke BP, Bremner SN, Zweifach BW, Skalak R, Schmid-Schonbein GW. 1997. Mechanisms for increased. blood flow resistance due to leukocytes. Am. J. Physiol. Heart Circ. Physiol. 273:H2884-90.
68. Helmke BP, Sugihara-Seki M, Skalak R, Schmid-Schonbein GW. 1998. A mechanism for erythrocytemediated. elevation of apparent viscosity by leukocytes in vivo without adhesion to the endothelium. Biorheology 35:437-48.
69. Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, et al. 2008. Tumor recovery by angiogenic switch from. sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am. J. Pathol. 173:1173-85.
70. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, et al. 1998. Regulation of transport pathways in. tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 95:4607-12.
71. Hofmann M, Schultz M, Bernd A, Bereiter-Hahn J, Kaufmann R, Kippenberger S. 2007. Long-term lowering. of tumour interstitial fluid pressure reduces Ki-67 expression. J. Biomech. 40:2324-29.
72. Holmgren L, Oreilly MS, Folkman J. 1995. Dormancy of micrometastases: balanced proliferation and apoptosis. in the presence of angiogenesis suppression. Nat. Med. 1:149-53.
73. Hou HW, Lee WC, Leong MC, Sonam S, Vedula SRK, Lim CT. 2011. Microfluidics for applications in cell. mechanics and mechanobiology. Cell. Mol. Bioeng. 4:591-602.
74. Huang Y, Agrawal B, Sun DD, Kuo JS, Williams JC. 2011. Microfluidics-based devices: new tools for studying. cancer and cancer stem cell migration. Biomicrofluidics 5:013412.
75. Ide AG, Baker NH, Warren SL. 1939. Vascularization of the Brown Pearce rabbit epithelioma transplant as. seen in the transparent ear chamber. Am. J. Roentgenol. 42:891-99.
76. Iruela-Arispe ML, Davis GE. 2009. Cellular and molecular mechanisms of vascular lumen formation. Dev. Cell 16:222-31.
77. Jain RK. 1987. Transport of molecules in the tumor interstitium: a review. Cancer Res. 47:3039-51.
78. Jain RK. 1988. Determinants of tumor blood flow: a review. Cancer Res. 48:2641-58.
79. Jain RK. 1990. Vascular and interstitial barriers top delivery of therapeutic agents in tumors. Cancer Metastasis. Rev. 9:253-66.
80. Jain RK, Tong RT, Munn LL. 2007. Effect of vascular normalization by antiangiogenic therapy on interstitial. hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer. Res. 67:2729-35.
81. Joyce JA, Pollard JW. 2009. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9:239-52.
82. Kamoun WS, Chae SS, Lacorre DA, Tyrrell JA, Mitre M, et al. 2010. Simultaneous measurements of RBC. velocity, flux, hematocrit and shear rate in vascular networks. Nat. Methods 7:655-60.
83. Kang H, Fan Y, Deng X. 2011. Vascular smoothmuscle cell glycocalyxmodulates shear-induced proliferation,. migration, and no production responses. Am. J. Physiol. Heart Circ. Physiol. 300:H76-83.
84. Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P. 2009. Biomechanical regulation of blood vessel. growth during tissue vascularization. Nat. Med. 15:657-64.
85. Kim M, Sarelius I. 2003. Distributions of wall shear stress in venular convergences of mouse cremaster muscle. Microcirculation 10:167-78.
86. King MR, Hammer DA. 2001a. Multiparticle adhesive dynamics: hydrodynamic recruitment of rolling leukocytes. Proc. Natl. Acad. Sci. USA 98:14919-24.
87. King MR, Hammer DA. 2001b. Multiparticle adhesive dynamics: interactions between stably rolling cells. Biophys. J. 81:799-813.
88. Klein EA, Yin L, Kothapalli D, Castagnino P, Byfield FJ, et al. 2009. Cell-cycle control by physiological matrix. elasticity and in vivo tissue stiffening. Curr. Biol. 19:1511-18.
89. Koumoutsakos P. 2005. Multiscale flow simulations using particles. Annu. Rev. Fluid Mech. 37:457-87.
90. Krogh A. 1922. The Anatomy and Physiology of Capillaries. New Haven, CT: Yale Univ. Press.
91. Kuhn P, Bethel K. 2012. A fluid biopsy as investigating technology for the fluid phase of solid tumors. Phys. Biol. 9:010301.
92. Kuszyk BS, Corl FM, Franano FN, Bluemke DA, Hofmann LV, et al. 2001. Tumor transport physiology. Am. J. Roentgenol. 177:747-53.
93. Labelle M, Begum S, Hynes RO. 2011. Direct signaling between platelets and cancer cells induces an epithelialmesenchymal-like transition and promotes metastasis. Cancer Cell 20:576-90.
94. Lai MC, Peskin CS. 2000, An immersed boundary method with formal second-order accuracy and reduced. numerical viscosity. J. Comput. Phys. 160:705-19.
95. Leble V, Lima R, Dias R, Fernandes C, Ishikawa T, et al. 2011. Asymmetry of red blood cell motions in a. microchannel with a diverging and converging bifurcation. Biomicrofluidics 5:044120.
96. Leung D, Cachianes G, Kuang W, Goeddel D, Ferrara N. 1989. Vascular endothelial growth factor is a. secreted angiogenic mitogen. Science 246:1306-9.
97. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, et al. 1992. Angiogenesis, microvascular architecture,. microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma. LS174T in SCID mice. Cancer Res. 52:6553-60.
98. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. 2009. Matrix crosslinking forces tumor progression. by enhancing integrin signaling. Cell 139:891-906.
99. Levick JR, Michel CC. 2010. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87:198-210.
100. Levin M, Dawant B, Popel AS. 1986. Effect of dispersion of vessel diameters and lengths in stochastic networks. 2. Modeling of microvascular hematocrit distribution. Microvasc. Res. 31:223-34.
101. Li J, Dao M, Lim C, Suresh S. 2005. Spectrin-level modeling of the cytoskeleton and optical tweezers stretching. of the erythrocyte. Biophys. J. 88:3707-19.
102. Li J, Lykotrafitis G, Dao M, Suresh S. 2007. Cytoskeletal dynamics of human erythrocyte. Proc. Natl. Acad. Sci. USA 104:4937-42.
103. Li QS, Lee GYH, Ong CN, Lim CT. 2008. AFM indentation study of breast cancer cells. Biochem. Biophys. Res. Commun. 374:609-13.
104. Lianidou ES, Markou A. 2011. Circulating tumor cells in breast cancer: detection systems, molecular characterization,. and future challenges. Clin. Chem. 57:1242-55.
105. Lincoln B, Erickson H, Schinkinger S, Wottawah F, Mitchell D, et al. 2004. Deformability-based flow cytometry. Cytometry 59A:203-9.
106. Liu C, Krishnan J, Stebbing J, Xu XY. 2011. Use of mathematical models to understand anticancer drug. delivery and its effect on solid tumors. Pharmacogenomics 12:1337-48.
107. Liu Y, Liu WK. 2006. Rheology of red blood cell aggregation by computer simulation. J. Comput. Phys. 220:139-54.
108. Lo CM, Wang HB, Dembo M, Wang Yl. 2000. Cell movement is guided by the rigidity of the substrate. Biophys. J. 79:144-52.
109. Long M, Sato M, Lim CT, Wu J, Adachi T, Inoue Y. 2011. Advances in experiments and modeling in microand. nano-biomechanics: a mini review. Cell. Mol. Bioeng. 4:327-39.
110. Lowengrub JS, Frieboes HB, Jin F, Chuang YL, Li X, et al. 2010. Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23:R1-91.
111. Lucitti JL, Jones EAV, Huang C, Chen J, Fraser SE, Dickinson ME. 2007. Vascular remodeling of the mouse. yolk sac requires hemodynamic force. Development 134:3317-26.
112. Macklin P, McDougall S, Anderson A, Chaplain M, Cristini V, Lowengrub J. 2009. Multiscale modelling and. nonlinear simulation of vascular tumour growth. J. Math. Biol. 58:765-98.
113. Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of. tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41:189-207.
114. Maeda H. 2010. Tumor-selective delivery ofmacromolecular drugs via the EPR effect: background and future. prospects. Bioconjug. Chem. 21:797-802.
115. Makanya AN, Hlushchuk R, Djonov VG. 2009. Intussusceptive angiogenesis and its role in vascular morphogenesis,. patterning, and remodeling. Angiogenesis 12:113-23.
116. Mazzone M, Dettori D, de Oliveira RL, Loges S, Schmidt T, et al. 2009. Heterozygous deficiency of PHD2. restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839-51.
117. McDougall SR, Anderson ARA, Chaplain MAJ, Sherratt JA. 2002. Mathematical modelling of flow. through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64:673-702.
118. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, et al. 2004. HER-2 gene amplification can be acquired as. breast cancer progresses. Proc. Natl. Acad. Sci. USA 101:9393-98.
119. Merks RMH, Perryn ED, Shirinifard A, Glazier JA. 2008. Contact-inhibited chemotaxis in de novo and. sprouting blood-vessel growth. PLoS Comput. Biol. 4:e1000163.
120. Michel CC. 1997. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance. after 100 years. Exp. Physiol. 82:1-30.
121. Michor F, Liphardt J, Ferrari M, Widom J. 2011. What does physics have to do with cancer? Nat. Rev. Cancer. 11:657-70.
122. Milde F, Bergdorf M, Koumoutsakos P. 2008. A hybrid model for three-dimensional simulations of sprouting. angiogenesis. Biophys. J. 95:3146-60.
123. Miles FL, Pruitt FL, van Golen KL, Cooper CR. 2008. Stepping out of the flow: capillary extravasation in. cancer metastasis. Clin. Exp. Metastasis 25:305-24.
124. Mukherjee S. 2010. The Emperor of All Maladies: A Biography of Cancer. New York: Scribner.
125. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. 2007. Isolation of rare circulating tumour. cells in cancer patients by microchip technology. Nature 450:1235-39.
126. Nagy JA, Chang SH, Dvorak AM, Dvorak HF. 2009. Why are tumour blood vessels abnormal and why is it. important to know? Br. J. Cancer 100:865-69.
127. Narang AS, Varia S. 2011. Role of tumor vascular architecture in drug delivery. Adv. Drug Deliv. Rev. 63:640-58.
128. Nasu R, Kimura H, Akagi K, Murata T, Tanaka Y. 1999. Blood flow influences vascular growth during tumour. angiogenesis. Br. J. Cancer 79:780-86.
129. Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, et al. 2005. Elevated physiologic tumor. pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin. Cancer Res. 11:2389-97.
130. Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, et al. 2008. Tumor interstitial fluid pressure may. regulate angiogenic factors in osteosarcoma. J. Orthop. Res. 26:1520-25.
131. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability: an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11:220-28.
132. Nelson CM, Inman JL, Bissell MJ. 2008. Three-dimensional lithographically defined organotypic tissue arrays. for quantitative analysis of morphogenesis and neoplastic progression. Nat. Protoc. 3:674-78.
133. Noguchi H, Gompper G. 2005. Shape transitions of fluid vesicles and red blood cells in capillary flows. Proc. Natl. Acad. Sci. USA 102:14159-64.
134. Nordling CO. 1953. A new theory on the cancer-inducing mechanism. Br. J. Cancer 7:68-72.
135. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. 2005. Stromal fibroblasts present. in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-48.
136. Padera TP, Stoll BR, Tooredman JB, Capen D, Tomaso Ed, Jain RK. 2004. Pathology: Cancer cells compress. intratumour vessels. Nature 427:695.
137. Paget S. 1889. The distribution of secondary growths in cancer of the breast. Lancet 1:571-73.
138. Paku S, Dezso K, Bugyik E, Tovari J, Timar J, et al. 2011. A new mechanism for pillar formation during. tumor-induced intussusceptive angiogenesis. Am. J. Pathol. 179:1573-85.
139. Pan WX, Fedosov DA, Caswell B, Karniadakis GE. 2011. Predicting dynamics and rheology of blood flow: a. comparative study of multiscale and low-dimensional models of red blood cells. Microvasc. Res. 82:163-70.
140. Pantel K, Alix-Panabieres C. 2010. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol. Med. 16:398-406.
141. Pappu V, Doddi SK, Bagchi P. 2008. A computational study of leukocyte adhesion and its effect on flow. pattern in microvessels. J. Theor. Biol. 254:483-98.
142. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform. for cancer therapy. Nat. Nanotechnol. 2:751-60.
143. Peirce SM. 2008. Computational and mathematical modeling of angiogenesis. Microcirculation 15:739-51.
144. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW. 2009. Mediating tumor targeting efficiency. of nanoparticles through design. Nano Lett. 9:1909-15.
145. Pivkin IV, Karniadakis GE. 2008. Accurate coarse-grained modeling of red blood cells. Phys. Rev. Lett. 101:118105.
146. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant. and stem cell traits. Nat. Rev. Cancer 9:265-73.
147. Popel AS, Gross JF. 1979. Analysis of oxygen diffusion from arteriolar networks. Am. J. Physiol. 237:H681-89.
148. Potente M, Gerhardt H, Carmeliet P. 2011. Basic and therapeutic aspects of angiogenesis. Cell 146:873-87.
149. Pozrikidis C. 2005. Numerical simulation of cell motion in tube flow. Ann. Biomed. Eng. 33:165-78.
150. Praprotnik M, Delle Site L, Kremer K. 2008. Multiscale simulation of soft matter: from scale bridging to. adaptive resolution. Annu. Rev. Phys. Chem. 59:545-71.
151. Pries AR, Hopfner M, leNoble F, Dewhirst MW, SecombTW. 2010. Theshunt problem: control of functional. shunting in normal and tumour vasculature. Nat. Rev. Cancer 10:587-93.
152. Pries AR, Secomb TW, Gaehtgens P. 1995. Structure and hemodynamics of microvascular networks: heterogeneity. and correlations. Am. J. Physiol. Heart Circ. Physiol. 269:H1713-22.
153. Pries AR, Secomb TW, Gaehtgens P. 1996. Biophysical aspects of blood flow in the microvasculature. Cardiovasc. Res. 32:654-67.
154. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. 2009. Matrix density-induced mechanoregulation of breast. cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28:4326-43.
155. Qutub A, Mac Gabhann F, Karagiannis E, Vempati P, Popel A. 2009. Multiscale models of angiogenesis. IEEE Eng. Med. Biol. Mag. 28:14-31.
156. Reasor DA, Clausen JR, Aidun CK. 2012. Coupling the lattice-Boltzmann and spectrin-link methods for the. direct numerical simulation of cellular blood flow. Int. J. Numer. Methods Fluids 68:767-81.
157. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, et al. 2007. Exploiting lymphatic transport. and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25:1159-64.
158. Reitsma S, Slaaf DW, Vink H, van Zandvoort M, Egbrink M. 2007. The endothelial glycocalyx: composition,. functions, and visualization. Pflugers Arch. Eur. J. Physiol. 454:345-59.
159. Renkin EM. 1985. B. W. Zweifach award lecture: regulation of the microcirculation. Microvasc. Res. 30:251-63.
160. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, et al. 2003. Fluid shear stress and the vascular. endothelium: for better and for worse. Prog. Biophys. Mol. Biol. 81:177-99.
161. Ribatti D, Djonov V. 2012. Intussusceptive microvascular growth in tumors. Cancer Lett. 316:126-31.
162. Rutkowski JM, Swartz MA. 2007. A driving force for change: interstitial flow as a morphoregulator. Trends. Cell Biol. 17:44-50.
163. Salk JJ, Fox EJ, Loeb LA. 2010. Mutational heterogeneity in human cancers: origin and consequences. Annu. Rev. Pathol. 5:51-75.
164. Sarimollaoglu M, Nedosekin DA, Simanovsky Y, Galanzha EI, Zharov VP. 2011. In vivo photoacoustic timeof-flight velocity measurement of single cells and nanoparticles. Opt. Lett. 36:4086-88.
165. Schmid-Schonbein GW, Murakami H. 1985. Blood flow in contracting arterioles. Int. J. Microcirc. Clin. Exp. 4:311-28.
166. Schulze C, Firth JA. 1992. The interendothelial junction in myocardial capillaries: evidence for the existence. of regularly spaced, cleft-spanning structures. J. Cell Sci. 101:647-55.
167. Secomb TW, Hsu R. 1997. Resistance to blood flow in nonuniform capillaries. Microcirculation 4:421-27.
168. Secomb TW, Hsu R, Pries AR. 2002. Blood flow and red blood cell deformation in nonuniform capillaries:. effects of the endothelial surface layer. Microcirculation 9:189-96.
169. Shieh A. 2011. Biomechanical forces shape the tumor microenvironment. Ann. Biomed. Eng. 39:1379-89.
170. Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, et al. 2002. MMP-2 and MMP-9 expression. in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Treat. 72:69-77.
171. Skotheim JM, Secomb TW. 2007. Red blood cells and other nonspherical capsules in shear flow: oscillatory. dynamics and the tank-treading-to-tumbling transition. Phys. Rev. Lett. 98:078301.
172. Sokolowski S, Herrmann H. 1992. Dynamic phase separation of a fluid mixture. Europhys. Lett. 18:415-20.
173. Song JW, Munn LL. 2011. Fluid forces control endothelial sprouting. Proc. Natl. Acad. Sci. USA 108:15342-47.
174. Starling EH. 1896. On the absorption of fluids from the connective tissue spaces. J. Physiol. 19:312-26.
175. Steeg PS. 2006. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12:895-904.
176. Stephanou A, McDougall SR, Anderson ARA, Chaplain MAJ. 2006. Mathematical modelling of the influence. of blood rheological properties upon adaptative tumour-induced angiogenesis. Math. Comput. Model. 44:96-123.
177. Stokes CL, Lauffenburger DA. 1991. Analysis of the roles of microvessel endothelial cell random motility and. chemotaxis in angiogenesis. J. Theor. Biol. 152:377-403.
178. Stoler D, Chen N, Basik M, Kahlenberg M, Rodriguez-Bigas M, et al. 1999. The onset and extent of genomic. instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. USA 96:15121-26.
179. Stroh M, Zimmer J, Duda D, Levchenko T, Cohen K, et al. 2005. Quantum dots spectrally distinguish multiple. species within the tumor milieu in vivo. Nat. Med. 11:678-82.
180. Struckhoff AP, Vitko JR, Rana MK, Davis CT, Foderingham KE, et al. 2010. Dynamic regulation of ROCK. in tumor cells controls CXCR4-driven adhesion events. J. Cell Sci. 123:401-12.
181. Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, et al. 2012. Causes, consequences,. and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl. Acad. Sci. USA. 109:15101-8.
182. Styp-Rekowska B, Hlushchuk R, Pries AR, Djonov V. 2011. Intussusceptive angiogenesis: pillars against the. blood flow. Acta Physiol. 202:213-23.
183. Sugihara-Seki M, Akinaga T, Itano T. 2008. Flow across microvessel walls through the endothelial surface. glycocalyx and the interendothelial cleft. J. Fluid Mech. 601:229-52.
184. Sugihara-Seki M, Fu BMM. 2005. Blood flow and permeability in microvessels. Fluid Dyn. Res. 37:82-132.
185. Sugihara-Seki M, Minamiyama M, Hanai S. 1989. Vascular resistance of arterioles with nonuniform diameters. Microvasc. Res. 38:148-54.
186. Sugihara-Seki M, Skalak R. 1997. Force acting on spheres adhered to a vessel wall. Biorheology 34:249-60.
187. Sun HW, Li CJ, Chen HQ, Lin HL, Lv HX, et al. 2007. Involvement of integrins, MAPK, and NF-κB. in regulation of the shear stress-induced MMP-9 expression in endothelial cells. Biochem. Biophys. Res. Commun. 353:152-58.
188. Sun S, Wheeler MF, Obeyesekere M, Patrick CW Jr. 2005. A deterministic model of growth factor-induced. angiogenesis. Bull. Math. Biol. 67:313-37.
189. Suresh S. 2007a. Biomechanics and biophysics of cancer cells. Acta Biomater. 3:413-38.
190. Suresh S. 2007b. Nanomedicine: elastic clues in cancer detection. Nat. Nanotechnol. 2:748-49.
191. Suzuki M, Takahashi T, Sato T. 1987. Medial regression and its functional significance in tumor supplying. host arteries: a morphometric study of hepatic arteries in human livers with hepatocellular carcinoma. Cancer 59:444-50.
192. Swartz MA, Lund AW. 2012. Lymphatic and interstitial flow in the tumour microenvironment: linking. mechanobiology with immunity. Nat. Rev. Cancer 12:210-19.
193. Tarbell J, Weinbaum S, Kamm R. 2005. Cellular fluid mechanics and mechanotransduction. Ann. Biomed. Eng. 33:1719-23.
194. Torchilin V. 2011. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63:131-35.
195. Travasso RDM, Corvera Poir E, Castro M, Rodrguez-Manzaneque JC, Hernndez-Machado A. 2011. Tumor. angiogenesis and vascular patterning: a mathematical model. PLoS ONE 6:e19989.
196. Ulrich TA, de Juan Pardo EM, Kumar S. 2009. The mechanical rigidity of the extracellular matrix regulates. the structure, motility, and proliferation of glioma cells. Cancer Res. 69:4167-74.
197. Vakoc BJ, Lanning RM, Tyrrell JA, Padera TP, Bartlett LA, et al. 2009. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat. Med. 15:1219-23.
198. Valastyan S, Weinberg RA. 2011. Tumormetastasis: molecular insights and evolving paradigms. Cell 147:275-92.
199. Vicaut E. 1986. Statistical estimation of parameters in microcirculation. Microvasc. Res. 32:244-47.
200. Weinbaum S. 1998. 1997 Whitaker Distinguished Lecture: models to solve mysteries in biomechanics at the. cellular level; a new view of fiber matrix layers. Ann. Biomed. Eng. 26:627-43.
201. Weinbaum S, Zhang X, Han Y, Vink H, Cowin SC. 2003. Mechanotransduction and flowacross the endothelial. glycocalyx. Proc. Natl. Acad. Sci. USA 100:7988-95.
202. Wirtz D, Konstantopoulos K, Searson PC. 2011. The physics of cancer: the role of physical interactions and. mechanical forces in metastasis. Nat. Rev. Cancer 11:512-22.
203. Wu JS, Aidun CK. 2010. Simulating 3Ddeformable particle suspensions using lattice Boltzmannmethod with. discrete external boundary force. Int. J. Numer. Methods Fluids 62:765-83.
204. Wuang SC, Ladoux B, Lim CT. 2011. Probing the chemo-mechanical effects of an anti-cancer drug emodin. on breast cancer cells. Cell. Mol. Bioeng. 4:466-75.
205. Yamane T, Mitsumata M, Yamaguchi N, Nakazawa T, Mochizuki K, et al. 2010. Laminar high shear stress upregulates. type IV collagen synthesis and down-regulates MMP-2 secretion in endothelium: a quantitative. analysis. Cell Tissue Res. 340:471-79.
206. Yan Z, Acrivos A, Weinbaum S. 1991. Fluid skimming and particle entrainment into a small circular side pore. J. Fluid Mech. 229:1-27.
207. Young J. 1959. The invasive growth of malignant tumours: an experimental interpretation based on elasticjelly. models. J. Pathol. Bacteriol. 77:321-39.
208. Yu J, Rak J, Coomber B, Hicklin D, Kerbel R. 2002. Effect of p53 status on tumor response to antiangiogenic. therapy. Science 295:1526-28.
209. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. 2011. Circulating tumor cells: approaches to isolation. and characterization. J. Cell Biol. 192:373-82.
210. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. 1994a. Microvascular permeability. and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54:3352-56.
211. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. 1994b. Vascular-permeability and microcirculation. of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54:4564-68.
212. Zhu C, Yago T, Lou J, Zarnitsyna VI, McEver RP. 2008. Mechanisms for flow-enhanced cell adhesion. Ann. Biomed. Eng. 36:604-21.